Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic.
BACKGROUND
A fast, proton echo-planar spectroscopic imaging (PEPSI) technique, capable of simultaneously measuring metabolites from multiple brain regions, was used to investigate the anatomical distribution and magnitude of brain lactate responses to intravenous lactate infusion among subjects with panic disorder and control subjects.


METHODS
Fifteen subjects with panic disorder and 10 control subjects were studied. All subjects were medication free and met DSM-IV criteria for panic disorder, or, for controls, no Axis I psychiatric disorder. Two-dimensional axial metabolite images having 1-cm3 spatial resolution were acquired at 61/2-minute intervals during 3 conditions: a 20-minute baseline, 20-minute 0.5-mol/L sodium lactate infusion, and 15-minute postinfusion period.


RESULTS
Intravenous lactate infusion increased brain lactate levels throughout the axial brain section studied in all subjects. Panic-disordered subjects had significantly greater global brain lactate increases in response to lactate infusion. Lateralization of brain lactate response did not occur, nor were discrete regional loci of elevated lactate observed. Cerebrospinal fluid lactate changes corresponded to lactate changes in brain tissue. Severity of symptoms provoked by lactate infusion did not directly correlate with brain lactate response.


CONCLUSIONS
Greater overall rises in brain lactate among subjects with panic disorder compared with controls occurred in response to lactate infusion. We were unable to detect a distinct regional pattern for magnitude differences in brain lactate rise by which to identify a specific neuroanatomical substrate underlying a lactate-induced panic response. The wide anatomical distribution of these brain lactate increases suggest metabolic and/or neurovascular mechanisms for the abnormal rise in subjects with panic disorder.
Dager
S R
SR
Department of Psychiatry, Diagnostic Imaging Sciences Center, University of Washington School of Medicine, Seattle 98105-6099, USA. srd@u.washington.edu
Friedman
S D
SD
Heide
A
A
Layton
M E
ME
Richards
T
T
Artru
A
A
Strauss
W
W
Hayes
C
C
Posse
S
S
D000328:Adult; D001921:Brain / Q000098:blood supply / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D017352:Echo-Planar Imaging / Q000295:instrumentation*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007773:Lactates / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy / Q000295:instrumentation*; D008297:Male; D016584:Panic Disorder / Q000139:chemically induced* / Q000175:diagnosis / Q000378:metabolism*; D011522:Protons; D012039:Regional Blood Flow; D012720:Severity of Illness Index; D019354:Sodium Lactate / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics
D007773:Lactates; D011522:Protons; D019354:Sodium Lactate